Sophia Genetics Sa Stock News

BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Off

Equities analysts predict that SOPHiA Genetics SA (NASDAQ:SOPH) will post $11.33 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for SOPHiA Genetics earnings, with estimates ranging from $11.26 million to $11.40 million. The firm is scheduled to announce its next earnings results on Wednesday, February 9th. On average, analysts []

SOPHiA Genetics SA (NASDAQ:SOPH) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 550,400 shares, an increase of 17.2% from the November 15th total of 469,700 shares. Approximately 1.1% of the shares of the stock are sold short. Based on [] The post SOPHiA Genetics SA (NASDAQ:SOPH) Short Interest Update appeared first on ETF Daily News .

Wall Street brokerages forecast that SOPHiA Genetics SA (NASDAQ:SOPH) will post earnings of ($0.34) per share for the current fiscal quarter, Zacks reports. Two analysts have made estimates for SOPHiA Genetics earnings, with the lowest EPS estimate coming in at ($0.36) and the highest estimate coming in at ($0.32). The firm is expected to report []

SOPHiA Genetics SA (NASDAQ:SOPH) shares fell 6.4% during trading on Friday . The company traded as low as $12.53 and last traded at $12.53. 230 shares were traded during mid-day trading, a decline of 100% from the average session volume of 95,414 shares. The stock had previously closed at $13.38. A number of research firms []

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and

Wall Street brokerages expect that SOPHiA Genetics SA (NASDAQ:SOPH) will report sales of $11.33 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for SOPHiA Genetics earnings, with the lowest sales estimate coming in at $11.26 million and the highest estimate coming in at $11.40 million. The company []

Brokerages expect SOPHiA Genetics SA (NASDAQ:SOPH) to announce earnings per share of ($0.34) for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for SOPHiA Genetics’ earnings, with the highest EPS estimate coming in at ($0.32) and the lowest estimate coming in at ($0.36). The business is scheduled to announce its next […]

SOPHiA GENETICS SA (SOPH) CEO Jurgi Camblong on Q3 2021 Results - Earnings Call Transcript

BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open

BOSTON and LAUSANNE, Switzerland, Oct. 12, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven med

BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Health

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open

SÃO PAULO, Brazil and BOSTON, Aug. 24, 2021 /PRNewswire/ -- Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH)